At the PAN Fall Conference, we learned from Dr. Lianping (Mint) Ti about short-course direct-acting antiviral (DAA) drugs for hepatitis C (HCV). These well-tolerated drugs have demonstrated cure rates of 95% and have been available in British Columbia (BC) since 2014, but their dispensation has been limited to individuals with advanced liver disease due to… Read more »
The Hepatitis C Care Cascade: From Diagnosis to Care and Treatment in British Columbia
Posted On: Wednesday, March 29th, 2017